Effect of Deguelin on UVB-Induced Skin Carcinogenesis

References

• Mukhtar H, Agarwal R. Skin cancer chemoprevention. J Invest Dermatol 1996; 1: 209–214.
   Google Scholar
• Einspahr JG, Stratton SP, Bowden CT, Alberts DS. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol 2002; 41: 269–285.
   PubMed Web of Science ®Google Scholar
• Gupta S, Mukhtar H. Chemoprevention of skin cancer: current status and future prospects. Cancer Metastasis Rev 2002; 21: 363–380.
   PubMed Web of Science ®Google Scholar
• De Gruijl FR. Photocarcinogenesis: UVA vs. UVB radia-tion. Skin Pharmacol Appl Skin Physiol 2002; 15: 316–320.
   PubMedGoogle Scholar
• Gerhäuser C, Mar W, Lee SK, et al. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nature Med 1995; 1: 260–266.
   PubMed Web of Science ®Google Scholar
• Udeani CO, Gerhäuser C, Thomas CF, et al. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Res 1997; 57: 3424–3428.
   PubMed Web of Science ®Google Scholar
• Anzeveno PB. Rotenoid interconversion: synthesis of deguelin from rotenone. J Org Chem 1979; 44: 2578–2580.
   Web of Science ®Google Scholar
• Gerhäuser C, Lee SK, Kosmeder JW, et al. Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent. Cancer Res 1997; 57: 3429–3435.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Salt IP, Hawley SA, Davies SP. AMP-acti-vated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 1999; 338: 717–722.
   PubMed Web of Science ®Google Scholar
• Hawley SA, Davison M, Woods A, et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 1996; 271: 27879–27887.
   PubMed Web of Science ®Google Scholar
• Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 1999; 24: 22–25.
   PubMed Web of Science ®Google Scholar
• Horman S, Browne G, Krause U, et al. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 2002; 12: 1419-1423.
   Google Scholar
• Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002; 277: 23977–23980.
   PubMed Web of Science ®Google Scholar
• Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, Cohen RA. Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent 5er1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem 2002; 277: 32552–32557.
   PubMed Web of Science ®Google Scholar
• Wang W, Fan J, Yang X, et al. AMP-activated kinase regulates cytoplasmic HuR. Mol Cell Biol 2002; 22: 3425–3436.
   PubMed Web of Science ®Google Scholar
• Wang IN, Yang X, Lopez de Silanes I, Carling D, Gorospe M. Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J Biol Chem 2003; 278: 27016–27023.
   Google Scholar
• Meisse D, Van de Casteele M, Beauloye C, et al. Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FESS Lett 2002; 526: 38–42.
   PubMed Web of Science ®Google Scholar
• Kefas BA, Cai Y, Ling Z, et al. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol 2003; 30: 151–161.
   PubMed Web of Science ®Google Scholar
• Li J, Jiang P, Robinson M, Lawrence TS, Sun Y. AMPK-betal subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression. Carcinogenesis 2003; 24: 827–834.
   PubMed Web of Science ®Google Scholar
• Barthel A, Schmoll D, Kruger KD, Roth RA, Joost HG. Regulation of the forkhead transcription factor FKHR (FOX01a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 2002; 143: 3183-3186.
   Google Scholar
• Hong YH, Varanasi US, Yang W, Leff T. AMP-activat-ed protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 2003; 278: 27495–27501.
   PubMed Web of Science ®Google Scholar
• Viollet B, Andreelli F, Jorgensen SB., et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 2003; 111: 91–98.
   Google Scholar
• Zong H, Ren JM, Young LH, et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 2002; 99: 15983–15987.
   PubMed Web of Science ®Google Scholar
• Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 2003; 278: 31000–31006.
   PubMed Web of Science ®Google Scholar
• Hallows KR, McCane JE, Kemp BE, Witters LA, Foskett JK. Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane con-ductance regulator activity in lung submucosal cells. J Biol Chem 2003; 278: 998–1004.
   PubMed Web of Science ®Google Scholar
• Da Silva Xavier G, Leclerc I, Varadi A, Tsuboi T, Moule SK, Rutter GA. Role for AMP-activated protein kinase in glu-cose-stimulated insulin secretion and preproinsulin gene expression. Biochem J 2003; 371: 761–774.
   PubMed Web of Science ®Google Scholar
• Yang W, Hong YH, Shen XQ, Frankowski C, Camp HS, Leff T. Regulation of transcription by AMP-activated pro-tein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J Biol Chem 2001; 276: 38341–38344.
   PubMed Web of Science ®Google Scholar
• Fryer LC, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 2002; 277: 25226–25232.
   PubMed Web of Science ®Google Scholar
• Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimu-lates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002; 415: 339–343.
   PubMed Web of Science ®Google Scholar
• Heilbronn LK, Smith SR, Ravussin E. The insulin-sensi-tizing role of the fat derived hormone adiponectin. Curr Pharm Des 2003; 9: 1411–1418.
   PubMed Web of Science ®Google Scholar
• Gollob MH, Green MS, Tang AS, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syn-drome. N Engl J Med 2001; 344: 1823–1831.
   PubMed Web of Science ®Google Scholar